Reported Reactions

Devices › Device types

FDA product code MGB · class 3 · Unknown

Device, hemostasis, vascular: medical device reports filed with FDA

124,366 reports carry this product code, 1996–2026; 30 brands with a page.

124,366
reports with this product code
0.5% of all MAUDE reports
7,087
reports, 12 months to August 2026
14,237 in the 12 months before
16.4%
classified as malfunction
62.3% across all reports
0.6%
classified as death, as reported
0.9% across all reports

Product code MGB is FDA's classification for "Device, hemostasis, vascular" (unknown panel), a class 3 device. 124,366 medical device reports carry this product code, 0.5% of the MAUDE database, from January 1996 to August 2026.

7,087 reports arrived in the 12 months to August 2026, down 50% from 14,237 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (82.5%), malfunction (16.4%) and death (0.6%). 30 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

BrandReportsLatest 12 monthsClassified as deathClassified as malfunction
Perclose Proglide 6f Suture Mediated Closure Smc System46,23500.3%1.5%
Perclose ProStyle Suture-Mediated Closure and Repair System16,441220%1.2%
Perclose ProStyle12,9352,3080.1%7.7%
Starclose Se Vascular Closure System6,43200.4%5.8%
Perclose ProGlide3,5526530.9%16.1%
Angio-Seal2,5239020.8%52.9%
Exoseal2,4411,1610%98.8%
6f Angio-Seal Vip Vascular Closure Device Ous1,81800.3%37.7%
Mynx Control1,7667680.1%96%
Starclose Vascular Closure System1,68581.2%46%
6f Angio-Seal Vip Vascular Closure Device Us1,61700.2%28.8%
Mynxgrip1,2544220.3%95.7%
Prostar Xl Suture-Mediated Closure1,23903.1%6.1%
Mynxgrip Vascular Closure Device 6f-7f1,16500.6%83.9%
8f Angio-Seal Vip Vascular Closure Device Ous1,05600.3%37.6%
6f Angio-Seal Vascular Closure Device Vip1,05304%0.1%
Mynxgrip Vascular Closure Device 5f97500%89.9%
Mynxgrip 6f/7f Vascular Closure Device95800.8%72.4%
Manta 18f852311.4%31.1%
Mynxgrip Vascular Closure Device 6f/7f79600%62.8%
Mynx Vascular Closure Device75401.5%21.1%
Mynx Control Venous7144360%35.9%
Vasoseal Vhd63601.3%21%
8f Angio-Seal Sts Plus Vascular Closure Device Ous62100.2%77.1%
6f Angio-Seal Vascular Closure Device Sts Plus42202.8%0%
Perclose A-T Suture Mediated Closure Smc System38101%5.8%
Closer Tsl6 French37302.7%10.2%
The Closer Ak37003%29.7%
8f Angio-Seal Vip Vascular Closure Device Us36600.8%34.2%
Mynxgrip 5f Vascular Closure Device35400%84.5%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Manufacturers named

Manufacturer (as written on reports)ReportsShare
Abbott Vascular55,33044.5%
Av-Temecula-Ct28,40122.8%
Terumo Medical8,7627%
Cordis US3,5382.8%
Cordis Santa Clara2,8022.3%
Abbott Vascular - Redwood City2,7822.2%
Accessclosure2,4962%
St Jude Medical2,3031.9%
Abbott Vascular Redwood City2,1221.7%
Perclose1,8411.5%
Essential Medical1,6161.3%
Cardinal Health Santa Clara1,5461.2%
Cardinal Health1,1360.9%
St Jude Medical Puerto Rico1,1110.9%
Cordis9920.8%

Reports by month, five years

06781,356Sep 2021: 654Oct 2021: 682Nov 2021: 777Dec 2021: 9572022Jan 2022: 723Feb 2022: 604Mar 2022: 737Apr 2022: 797May 2022: 776Jun 2022: 866Jul 2022: 838Aug 2022: 740Sep 2022: 743Oct 2022: 821Nov 2022: 840Dec 2022: 9722023Jan 2023: 946Feb 2023: 923Mar 2023: 1,168Apr 2023: 1,022May 2023: 1,118Jun 2023: 1,163Jul 2023: 1,102Aug 2023: 1,289Sep 2023: 1,141Oct 2023: 1,356Nov 2023: 1,119Dec 2023: 1,1822024Jan 2024: 1,173Feb 2024: 1,241Mar 2024: 1,169Apr 2024: 1,261May 2024: 996Jun 2024: 1,219Jul 2024: 1,079Aug 2024: 1,076Sep 2024: 1,034Oct 2024: 1,096Nov 2024: 1,097Dec 2024: 1,3212025Jan 2025: 1,214Feb 2025: 1,102Mar 2025: 1,163Apr 2025: 1,249May 2025: 1,059Jun 2025: 1,252Jul 2025: 1,325Aug 2025: 1,325Sep 2025: 1,255Oct 2025: 834Nov 2025: 508Dec 2025: 5762026Jan 2026: 375Feb 2026: 465Mar 2026: 572Apr 2026: 525May 2026: 523Jun 2026: 523Jul 2026: 484Aug 2026: 447

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death0.6%742
Injury82.5%102,642
Malfunction16.4%20,458
Other0.3%403
Not given0.1%121

Who filed

Manufacturer report97.5%121,288
Voluntary report1.2%1,448
User facility report0%0
Distributor report0%39
Not given1.3%1,591

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)ReportsShare
Failure to cycle35,32528.4%
Device operates differently than expectedthe device behaved unexpectedly16,88313.6%
Material separation8,5676.9%
Improper or incorrect procedure or method5,7384.6%
Positioning failure5,6234.5%
Difficult to removethe device was hard to remove5,2804.2%
Detachment of device component4,2103.4%
Malposition of device3,7293%
Insufficient device problem information3,6823%
Difficult to insertthe device was hard to insert2,7422.2%
Activation, positioning or separation problem2,1141.7%
Difficult to open or close2,0061.6%
Entrapment of device1,9681.6%
Patient device interaction problem1,8761.5%
Off-label use1,8701.5%
Breakthe device broke1,8441.5%
Defective component1,7931.4%
Retraction problem1,6141.3%
Mechanical jam1,5791.3%
Material rupture1,5671.3%

Questions about device, hemostasis, vascular reports

What is product code MGB?

FDA's classification code for "Device, hemostasis, vascular", class 3, reviewed by the unknown panel. Every device report carries the product code of the device involved.

How many reports carry this code?

124,366 reports through August 2026, 7,087 of them in the latest 12 months.

Which brands appear most often?

Perclose Proglide 6f Suture Mediated Closure Smc System (46,235), Perclose ProStyle Suture-Mediated Closure and Repair System (16,441), Perclose ProStyle (12,935), Starclose Se Vascular Closure System (6,432) and Perclose ProGlide (3,552). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.